Behavioral
Non-Contingent Feedback Training
Total Trials
2
Max Phase
-
Type
BEHAVIORAL
Molecule
-
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(100%)
Phase Distribution
Not Applicable
1
50%
Phase 2/3
1
50%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2/3Combined phases
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2/3Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Terminated(2)
Detailed Status
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
Phase 2/3
Trials by Phase
Phase 2/31 (50.0%)
N/A1 (50.0%)
Trials by Status
terminated2100%
Recent Activity
0 active trials
Showing 2 of 2
Clinical Trials (2)
Showing 2 of 2 trials
NCT05243459Phase 2/3
Testing the Efficacy of an Eye-tracking-based Treatment in Reducing Stress-related Symptoms in Veterans With PTSD
NCT05306197Not Applicable
Improving Performance of Combat Soldiers by Utilizing Attentional Training Based on Eye Tracking
All 2 trials loaded
Drug Details
- Intervention Type
- Behavioral
- Total Trials
- 2